EDITAS MEDICINE, INC. (EDIT) Operating income 2016–2025
EDITAS MEDICINE, INC. (EDIT) annual operating income history from SEC filings — each fiscal year as reported.
-$160.0MFY2025 · since FY2016: -$97.2M → -$160.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.0M | +36.3% |
| FY2024 | -$251.2M | -48.5% |
| FY2023 | -$169.2M | +25.1% |
| FY2022 | -$225.9M | -17.0% |
| FY2021 | -$193.1M | -43.2% |
| FY2020 | -$134.8M | +4.3% |
| FY2019 | -$140.9M | -23.9% |
| FY2018 | -$113.7M | +5.2% |
| FY2017 | -$119.9M | -23.4% |
| FY2016 | -$97.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EDIT financial trends
EDIT RevenueEDIT Net incomeEDIT Net marginEDIT Gross profitEDIT Gross marginEDIT Operating marginEDIT Operating cash flowEDIT Free cash flowEDIT Capital expendituresEDIT Return on equityEDIT Stock buybacksEDIT Dividends paidEDIT Total assetsEDIT Total liabilitiesEDIT Shareholders’ equityEDIT overview →